Stock Detail
$UNH
Healthcare · 30 tracked mentions in the last 90 days across 12 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
UNH leans undervalued across 6 creators and 12 classified valuation claims, with 8 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: fair value gap
So, on a forward earnings multiple basis, the stock is now trading at 16.5, which is still on the lower end of the range that the stock has traded at on this metric over the past few years. So, given the better-than-expected improvement in net earnings, I have revised my estimates for the amount of free cash flow that I expect the company to generate over the next several years. I have increased my estimates by several billion dollars, about $3 billion annually starting in 2026 and beyond. And that has had the effect of increasing the intrinsic value of the stock to $518.
Explicit claim • strong conviction • basis: growth vs multiple
So, if we do some math, ultimately what this means is that UNH could actually be closer to around $475 to $500 per share if they are valued based off their revenue and their margins
Explicit claim • strong conviction • basis: multiple relative
This is a stock where the market has clearly become much more nervous and that seems to be exactly why Congress has been stepping in.
Explicit claim • strong conviction • basis: drawdown discount
Stock is trading at multi-year lows with a significant discount.
Mention History
Latest mentions across all history
Feed